MedTrace Logo

Portico and Navitor India Clinical Trial

NCT05171712 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-15

Study results available
· View outcomes & findings →

Summary

The objective of this clinical trial is to collect data on procedural safety and device performance of the Portico and Navitor devices and FlexNav delivery system to treat patients with severe aortic stenosis in the Indian population.

Conditions

  • Aortic Valve Stenosis
  • Aortic Valve Failure
  • Aortic Insufficiency
  • Aortic Stenosis

Interventions

DEVICE

Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement for the treatment of patients with severe aortic stenosis

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Barathi Sethuraman · Abbott

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-06
Primary Completion
2024-12-21
Completion
2025-01-28
FDA Device
Yes

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05171712 on ClinicalTrials.gov